0000899243-20-004775.txt : 20200214 0000899243-20-004775.hdr.sgml : 20200214 20200214210020 ACCESSION NUMBER: 0000899243-20-004775 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200212 FILED AS OF DATE: 20200214 DATE AS OF CHANGE: 20200214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kusserow Paul B. K. CENTRAL INDEX KEY: 0001456688 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24260 FILM NUMBER: 20623029 MAIL ADDRESS: STREET 1: 780 SAN YSIDRO ROAD CITY: SANTA BARBARA STATE: CA ZIP: 93108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMEDISYS INC CENTRAL INDEX KEY: 0000896262 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 113131700 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 BUSINESS PHONE: 2252922031 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 FORMER COMPANY: FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP DATE OF NAME CHANGE: 19940819 FORMER COMPANY: FORMER CONFORMED NAME: M&N CAPITAL CORP DATE OF NAME CHANGE: 19930125 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-12 0 0000896262 AMEDISYS INC AMED 0001456688 Kusserow Paul B. K. 3854 AMERICAN WAY, SUITE A BATON ROUGE LA 70816 1 1 0 0 See Remarks Common Stock 2020-02-12 4 M 0 24546 0.00 A 79238 D Common Stock 71258 I By Trust Common Stock 621 I Through 401(k) Plan Restricted Stock Units 2020-02-12 4 M 0 24546 0.00 D Common Stock 24546 49092 D The information in this report is based on a plan statement dated as of December 31, 2019. On January 2, 2019, the Reporting Person was granted 73,638 RSUs, which are subject to performance-based vesting based on achievement of identified performance goals for each of fiscal years 2019 through 2021 and will vest after December 16, 2021 (which is the end of the term (the "Term") as set forth in the Amended and Restated Employment Agreement by and between the Reporting Person and the Issuer dated September 27, 2018), immediately upon the date of certification by the Compensation Committee of the Issuer's Board of Directors of the 2021 tranche performance measure, based on the certification by the Compensation Committee of the achievement of the identified performance goals for fiscal years 2019 through 2021, respectively (1/3 of the RSUs will vest based on achievement of the 2019 performance goal, 1/3 of the RSUs will vest based on achievement of the 2020 performance goal, and 1/3 of the RSUs will vest based on achievement of the 2021 performance goal), (Continued from Footnote 2) provided that Mr. Kusserow has not incurred a termination of employment prior to the end of the Term, and subject to certain pro-rated vesting provisions as provided in the award agreement for the RSUs. The performance criteria for fiscal year 2019 were met. CEO, President and Chairman of the Board /s/ Jennifer R. Guckert, pursuant to a power of attorney 2020-02-14